首页> 外国专利> THERAPEUTIC TRANSDERMAL BIOREACTOR OR TRAP PATCH FOR DIABETES, PHENYLKETONURIA, AUTOIMMUNE, HYPERCHOLESTERINAEMIA AND OTHER DISORDERS

THERAPEUTIC TRANSDERMAL BIOREACTOR OR TRAP PATCH FOR DIABETES, PHENYLKETONURIA, AUTOIMMUNE, HYPERCHOLESTERINAEMIA AND OTHER DISORDERS

机译:治疗性透皮生物反应器或陷阱贴片,用于治疗糖尿病、苯丙酮尿症、自身免疫、高胆固醇血症和其他疾病

摘要

A transdermal patch comprising: a microneedle in a protruding position, protruding from the transdermal patch; and immobilised functional molecules; wherein a fluid path is provided between the distal tip of the microneedle and the immobilised functional molecules; and the functional molecules are selected to interact with selected target molecules so as to convert or trap said target molecules. The device intends to dynamically curb the postprandial insulin spike offering an unprecedented therapeutic effect for diabetes and obesity with significant benefits in morbidity and without strict diet. The device offers unprecedented phenylketonuria management that removes the burden of strict diet. The device offers easy removal of autoantibodies, low density lipoprotein and other pathogenic molecules. The device can be used in any disorder that requires enzymatic replacement or elimination of pathogenic molecules via biochemical conversion or trapping.
机译:一种透皮贴片,其包括:从透皮贴片中突出的处于突出位置的微针;固定化功能分子;其中,在微针的远端尖端和固定的功能分子之间提供流体路径;所述功能分子被选择与所选目标分子相互作用,从而转化或捕获所述目标分子。该设备旨在动态抑制餐后胰岛素峰值,为糖尿病和肥胖症提供前所未有的治疗效果,显著降低发病率,且无需严格饮食。该设备提供了前所未有的苯丙酮尿症管理,消除了严格饮食的负担。该设备可轻松去除自身抗体、低密度脂蛋白和其他致病分子。该设备可用于任何需要酶替代或通过生化转化或捕获消除致病分子的疾病。

著录项

  • 公开/公告号EP3965846A2

    专利类型

  • 公开/公告日2022-03-16

    原文格式PDF

  • 申请/专利权人 LEKKOS VASILEIOS;

    申请/专利号EP20200732323

  • 发明设计人 LEKKOS VASILEIOS;

    申请日2020-06-03

  • 分类号A61M1/36;A61F2/02;A61M1/16;A61M1/34;A61M37;

  • 国家 EP

  • 入库时间 2022-08-24 23:53:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号